{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:21:02Z","timestamp":1694632862768},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1007\/bf02938388","type":"journal-article","created":{"date-parts":[[2008,8,15]],"date-time":"2008-08-15T07:31:28Z","timestamp":1218785488000},"page":"447-452","source":"Crossref","is-referenced-by-count":2,"title":["Primary aldosteronism"],"prefix":"10.1007","volume":"9","author":[{"given":"Richard J.","family":"Auchus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiemu E.","family":"Nwariaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02938388_CR1","first-page":"3","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn JW:Primary aldosteronism, a new clinical syndrome.J Lab Clin Med 1955,45:3\u201317.","journal-title":"J Lab Clin Med"},{"key":"BF02938388_CR2","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199812173392507","volume":"339","author":"A Ganguly","year":"1998","unstructured":"Ganguly A:Primary aldosteronism.N Engl J Med 1998,339:1828\u20131834.","journal-title":"N Engl J Med"},{"key":"BF02938388_CR3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Of importance Mulatero P, Stowasser M, Loh KC, et al.:Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.J Clin Endocrinol Metab 2004,89:1045\u20131050. This article summarizes the data supporting high prevalence of PA in multiple studies around the world.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02938388_CR4","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, et al.:A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.J Am Coll Cardiol 2006,48:2293\u20132300.","journal-title":"J Am Coll Cardiol"},{"key":"BF02938388_CR5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2165\/00003495-200262050-00001","volume":"62","author":"R Rocha","year":"2002","unstructured":"Rocha R, Williams GH:Rationale for the use of aldosterone antagonists in congestive heart failure.Drugs 2002,62:723\u2013731.","journal-title":"Drugs"},{"key":"BF02938388_CR6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.HYP.31.1.335","volume":"31","author":"D Rizzoni","year":"1998","unstructured":"Rizzoni D, Porteri E, Castellano M, et al.:Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure.Hypertension 1998,31:335\u2013341.","journal-title":"Hypertension"},{"key":"BF02938388_CR7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Of importance Rossi GP, Bernini G, Desideri G, et al.:Renal damage in primary aldosteronism: results of the PAPY Study.Hypertension 2006,48:232\u2013238. The report on renal outcome from the PAPY study, which showed greater proteinuria in PA than in primary HTN.","journal-title":"Hypertension"},{"key":"BF02938388_CR8","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","volume":"295","author":"LA Sechi","year":"2006","unstructured":"Of importance Sechi LA, Novello M, Lapenna R, et al.:Long-term renal outcomes in patients with primary aldosteronism.JAMA 2006,295:2638\u20132645. This study showed that the proteinuria in PA is more severe and progressive than in primary HTN; however, the proteinuria in PA is largely reversible with targeted treatment.","journal-title":"JAMA"},{"key":"BF02938388_CR9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjhyper.2005.05.013","volume":"19","author":"K Matsumura","year":"2006","unstructured":"Matsumura K, Fujii K, Oniki H, et al.:Role of aldosterone in left ventricular hypertrophy in hypertension.Am J Hypertens 2006,19:13\u201318.","journal-title":"Am J Hypertens"},{"key":"BF02938388_CR10","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/oxfordjournals.eurheartj.a014771","volume":"17","author":"JE Sanderson","year":"1996","unstructured":"Sanderson JE, Cockram CS, Yu CM, et al.:Myocardial fibrosis and hyperaldosteronism.Eur Heart J 1996,17:1761\u20131762.","journal-title":"Eur Heart J"},{"key":"BF02938388_CR11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al.:The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.N Engl J Med 1999,341:709\u2013717.","journal-title":"N Engl J Med"},{"key":"BF02938388_CR12","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, et al.:Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.N Engl J Med 2003,348:1309\u20131321.","journal-title":"N Engl J Med"},{"key":"BF02938388_CR13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/HYPERTENSIONAHA.106.086124","volume":"50","author":"NM Kaplan","year":"2007","unstructured":"Kaplan NM:Is there an unrecognized epidemic of primary aldosteronism? (Con).Hypertension 2007,50:454\u2013458.","journal-title":"Hypertension"},{"key":"BF02938388_CR14","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, et al.:Hyperaldosteronism among black and white subjects with resistant hypertension.Hypertension 2002,40:892\u2013896.","journal-title":"Hypertension"},{"key":"BF02938388_CR15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","volume":"66","author":"WF Young","year":"2007","unstructured":"Of importance Young WF:Primary aldosteronism: renaissance of a syndrome.Clin Endocrinol (Oxf) 2007,66:607\u2013618. Excellent and contemporary review of PA, including historical perspective, for the practicing endocrinologist.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF02938388_CR16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1148\/radiology.184.3.1509049","volume":"184","author":"JL Doppman","year":"1992","unstructured":"Doppman JL, Gill JR Jr, Miller DL, et al.:Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT.Radiology 1992,184:677\u2013682.","journal-title":"Radiology"},{"key":"BF02938388_CR17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2214\/ajr.141.2.299","volume":"141","author":"MA Geisinger","year":"1983","unstructured":"Geisinger MA, Zelch MG, Bravo EL, et al.:Primary hyperaldosteronism: comparison of CT, adrenal venography, and venous sampling.AJR Am J Roentgenol 1983,141:299\u2013302.","journal-title":"AJR Am J Roentgenol"},{"key":"BF02938388_CR18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1148\/radiology.217.3.r00dc52629","volume":"217","author":"M Korobkin","year":"2000","unstructured":"Korobkin M:CT characterization of adrenal masses: the time has come.Radiology 2000,217:629\u2013632.","journal-title":"Radiology"},{"key":"BF02938388_CR19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archsurg.141.5.497","volume":"141","author":"FE Nwariaku","year":"2006","unstructured":"Nwariaku FE, Miller BS, Auchus RJ, et al.:Primary hyperaldosteronism: advantages of adrenal vein sampling for subtype differentiation.Arch Surg 2006,141:497\u2013503.","journal-title":"Arch Surg"},{"key":"BF02938388_CR20","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young","year":"2004","unstructured":"Of major importance Young WF, Stanson AW, Thompson GB, et al.:Role for adrenal venous sampling in primary aldosterosism.Surgery 2004,136:1227\u20131235. The definitive study from the leaders in PA demonstrating the importance of AVS in the evaluation of PA.","journal-title":"Surgery"},{"key":"BF02938388_CR21","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1210\/jc.2006-2631","volume":"92","author":"RJ Auchus","year":"2007","unstructured":"Auchus RJ, Chandler DW, Singeetham S, et al.:Measurement of 18-hydroxycorticosterone during adrenal vein sampling in primary aldosteronism.J Clin Endocrinol Metab 2007,92:2648\u20132651.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02938388_CR22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-5347(05)64028-1","volume":"169","author":"P Meria","year":"2003","unstructured":"Meria P, Kempf BF, Hermieu JF, et al.:Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases.J Urol 2003,169:32\u201335.","journal-title":"J Urol"},{"key":"BF02938388_CR23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00464-001-8302-8","volume":"16","author":"LM Brunt","year":"2002","unstructured":"Brunt LM:The positive impact of laparoscopic adrenalectomy on complications of adrenal surgery.Surg Endosc 2002,16:252\u2013257.","journal-title":"Surg Endosc"},{"key":"BF02938388_CR24","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.surg.2006.07.039","volume":"140","author":"MK Walz","year":"2006","unstructured":"Of major importance Walz MK, Alesina PF, Wenger FA, et al.:Posterior retroperitoneoscopic adrenalectomy: results of 560 procedures in 520 patients.surgery 2006,140:943\u2013948. Excellent discussion of development of the technique of retroperitoneoscopic adrenalectomy with impressive outcomes.","journal-title":"surgery"},{"key":"BF02938388_CR25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","volume":"135","author":"AM Sawka","year":"2001","unstructured":"Sawka AM, Young WF, Thompson GB, et al.:Primary aldosteronism: factors associated with normalization of blood pressure after surgery.Ann Intern Med 2001,135:258\u2013261.","journal-title":"Ann Intern Med"},{"key":"BF02938388_CR26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archsurg.1996.01430180072015","volume":"131","author":"O Celen","year":"1996","unstructured":"Celen O, O\u2019Brien MJ, Melby JC, Beazley RM:Factors influencing outcome of surgery for primary aldosteronism.Arch Surg 1996,131:646\u2013650.","journal-title":"Arch Surg"},{"key":"BF02938388_CR27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/000313480507101015","volume":"71","author":"F Lumachi","year":"2005","unstructured":"Lumachi F, Ermani M, Basso SM, et al.:Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature.Am Surg 2005,71:864\u2013869.","journal-title":"Am Surg"},{"key":"BF02938388_CR28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","volume":"27","author":"GP Rossi","year":"1996","unstructured":"Rossi GP, Sacchetto A, Visentin P, et al.:Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.Hypertension 1996,27:1039\u20131045.","journal-title":"Hypertension"},{"key":"BF02938388_CR29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","volume":"131","author":"RP Ghose","year":"1999","unstructured":"Ghose RP, Hall PM, Bravo EL:Medical management of aldosterone-producing adenomas.Ann Intern Med 1999,131:105\u2013108.","journal-title":"Ann Intern Med"},{"key":"BF02938388_CR30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","volume":"49","author":"N Chapman","year":"2007","unstructured":"Of major importance Chapman N, Dobson J, Wilson S, et al.:Effect of spironolactone on blood pressure in subjects with resistant hypertension.Hypertension 2007,49:839\u2013845. The results of the ASCOT study, which demonstrated marked reductions in blood pressure with spironolactone in patients with resistant hypertension. These data confirmed the results of Nishizaka et al. [31] and suggest that a large fraction of resistant HTN is mediated by mineralocorticoids.","journal-title":"Hypertension"},{"key":"BF02938388_CR31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","volume":"16","author":"MK Nishizaka","year":"2003","unstructured":"Nishizaka MK, Zaman MA, Calhoun DA:Efficacy of lowdose spironolactone in subjects with resistant hypertension.Am J Hypertens 2003,16:925\u2013930.","journal-title":"Am J Hypertens"},{"key":"BF02938388_CR32","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2003-032149","volume":"89","author":"DG Levy","year":"2004","unstructured":"Levy DG, Rocha R, Funder JW:Distinguishing the antihypertensive and electrolyte effects of eplerenone.J Clin Endocrinol Metab 2004,89:2736\u20132740.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02938388_CR33","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1365-2168.2002.02261.x","volume":"89","author":"M Sywak","year":"2002","unstructured":"Sywak M, Pasieka JL:Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism.Br J Surg 2002,89:1587\u20131593.","journal-title":"Br J Surg"},{"key":"BF02938388_CR34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11906-007-0019-1","volume":"9","author":"F Fallo","year":"2007","unstructured":"Fallo F, Federspil G, Veglio F, Mulatero P:The metabolic syndrome in primary aldosteronism.Curr Hypertens Rep 2007,9:106\u2013111.","journal-title":"Curr Hypertens Rep"},{"key":"BF02938388_CR35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","volume":"351","author":"RS Vasan","year":"2004","unstructured":"Vasan RS, Evans JC, Larson MG, et al.:Serum aldosterone and the incidence of hypertension in nonhypertensive persons.N Engl J Med 2004,351:33\u201341.","journal-title":"N Engl J Med"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02938388.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02938388\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02938388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T01:27:21Z","timestamp":1631669241000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02938388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["BF02938388"],"URL":"https:\/\/doi.org\/10.1007\/bf02938388","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}